Longevity refers broadly to the duration of life, particularly the tendency or capacity of individuals, species or populations to survive to comparatively advanced ages. In demographic and biological contexts, the term can describe lifespan characteristics without necessarily implying exceptional or record-breaking survival. Human longevity can be examined at the level of an individual, such as the age reached by a particular person, or at the population level, such as average life expectancy or survival probabilities.
Longevity is therefore related to but distinct from life expectancy. Life expectancy is a statistical estimate of the average remaining years of life under specified mortality conditions, whereas longevity concerns the duration of life itself and is often used when discussing unusually long survival or determinants of extended lifespan. Maximum observed lifespan refers to the oldest age actually recorded in a population, while potential biological lifespan concerns theoretical limits that are more difficult to establish.
Human longevity has changed substantially over historical time, although the pattern is not simply a uniform extension of the maximum possible human lifespan. Improvements in sanitation, nutrition, vaccination, antibiotics, maternal care, safer childbirth and management of infectious disease produced major reductions in early and middle-adult mortality. As more people survived to older ages, population life expectancy increased substantially.
Further improvements have increasingly involved prevention and treatment of chronic diseases, cardiovascular risk management, cancer detection and treatment, and improved management of disability and other age-associated conditions. Longevity trends can differ considerably between countries, socioeconomic groups and historical periods because mortality is influenced by living conditions, healthcare systems, public policy, behaviour, environmental exposure and social inequality. Consequently, population longevity is not determined solely by medical technology or genetics. It reflects the combined effect of mortality risks throughout the life course.
Genetics contributes to individual differences in longevity, but human lifespan is a complex trait influenced by many genetic variants and environmental factors. Studies of families, twins and populations suggest that inherited factors contribute to variation in survival, particularly among people who reach very advanced ages, but genetic influence does not imply genetic determinism. Genes associated with lipid metabolism, cellular maintenance, inflammation, nutrient sensing and other biological processes have been investigated in relation to longevity.
Some variants have been repeatedly studied in long-lived populations, but associations can vary across populations and do not establish that a single gene determines lifespan. Environmental and behavioural factors can interact with genetic susceptibility, meaning that the same biological predisposition may produce different outcomes under different conditions. Longevity research therefore commonly uses epidemiological, demographic, genetic and molecular approaches together rather than treating inherited characteristics as an isolated explanation.
Longevity is closely related to mortality patterns. A population can experience increased life expectancy because mortality falls at younger ages even if the maximum age reached by the oldest individuals changes little. This distinction is important when interpreting historical increases in survival. Survival curves provide another useful framework by showing how mortality is distributed across ages.
Some species show mortality patterns very different from humans, including negligible senescence or unusual relationships between age and mortality, making comparative biology valuable for longevity research. Human mortality generally rises substantially with age, although the exact pattern and rate vary between populations. Exceptional longevity requires surviving successive age-specific risks, meaning that very old individuals represent a selected subset of survivors. This selection effect can complicate comparisons between very old individuals and younger populations because those who reach extreme ages may differ systematically in health, genetics and exposure history.
The oldest verified human lifespan provides information about observed longevity limits but does not establish a definitive biological maximum. Claims of extreme ages require reliable documentary evidence, particularly because errors in identity records, dates of birth and dates of death can create false age claims. Jeanne Calment of France is widely recognised as the oldest person whose age has been robustly validated, having reached 122 years and 164 days.
The validation of exceptional ages has therefore become an important methodological issue in demographic research. Maximum lifespan and average lifespan should not be confused: a small number of individuals reaching extreme ages does not mean that the population as a whole has similar longevity. Conversely, a rise in average life expectancy can occur without a dramatic increase in maximum observed age. These distinctions are essential when discussing whether human longevity has a fixed upper limit or whether that limit might change as mortality at older ages changes.
Longevity is also associated with the concept of healthspan, meaning the period of life spent in relatively good health and functional capacity. Extending life without preserving physical, cognitive and social functioning would produce a different outcome from extending both lifespan and healthspan. Research therefore increasingly considers measures such as disability-free survival, functional independence, cognitive health and quality of life alongside chronological survival.
Healthy longevity can be influenced by management of cardiovascular risk, maintenance of physical activity, adequate nutrition, prevention of avoidable injuries, vaccination, appropriate healthcare and social participation. These factors do not guarantee exceptional lifespan because individual outcomes remain probabilistic and affected by numerous determinants. Longevity should therefore not be reduced to a checklist of behaviours. At population level, interventions that shift mortality risks across large numbers of people can have substantial effects even when their impact on any individual is modest.
Longevity research includes demographic analysis, epidemiology, genetics, evolutionary biology, geroscience, molecular biology and comparative studies of other species. Researchers investigate whether mortality can be delayed, whether age-associated biological changes can be modified and whether interventions can extend healthy life rather than merely prolong survival with disease. Animal models have been valuable for identifying conserved biological pathways, but findings from organisms such as yeast, worms, flies and laboratory mice do not automatically translate into equivalent effects in humans.
Human observational studies can identify associations but are vulnerable to confounding, reverse causation and selection effects, while randomised trials can provide stronger evidence for specific interventions but may be difficult to conduct over the timescales relevant to lifespan. These methodological differences mean that claims about extending human longevity require careful separation of established demographic evidence from experimental findings and hypotheses.
Longevity has major social and economic implications because changes in survival alter population age structures, pension systems, healthcare requirements, labour markets, housing needs and patterns of intergenerational support. Increasing longevity does not necessarily mean that every additional year is spent in poor health, nor does it automatically determine retirement or dependency patterns. The consequences depend on how additional years are distributed across health, disability and participation.
Population ageing can result from increased longevity, declining fertility or both, and different societies experience these processes at different rates. Longevity is therefore simultaneously a biological, demographic and social concept. Understanding it requires distinguishing individual lifespan from population life expectancy, maximum observed age from average survival, and longer life from healthier life. These distinctions allow longevity to be studied without treating exceptional survival as representative of the broader human population.
